DD
53
-6
F
56
-3
CSCO
58
-2
OI
42
-3
GM
74
5
CB
57
2
CMG
66
-4
MCHP
34
-2
CFG
74
2
AIZ
82
2
AEP
54
6
PVH
60
-4
EXPD
43
-4
CAT
59
-2
RSG
65
-3
DE
42
3
CINF
53
3
ADBE
47
-9
SEE
53
3
FAST
57
-3
DD
53
-6
F
56
-3
CSCO
58
-2
OI
42
-3
GM
74
5
CB
57
2
CMG
66
-4
MCHP
34
-2
CFG
74
2
AIZ
82
2
AEP
54
6
PVH
60
-4
EXPD
43
-4
CAT
59
-2
RSG
65
-3
DE
42
3
CINF
53
3
ADBE
47
-9
SEE
53
3
FAST
57
-3
Financhill
Back

Easterly Government Properties Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
18

DEA
Easterly Government Properties

Last Price:
12.06
Seasonality Move:
2.68%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
18
Easterly Government Properties (DEA) is a Sell

Is Easterly Government Properties a Buy, Sell or Hold?

  • The current Easterly Government Properties [DEA] share price is $12.06. The Score for DEA is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • DEA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DEA Stock Price Chart

What is Easterly Government Properties's stock price today?

  • The Easterly Government Properties share price today is $12.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DEA is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

DEA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 21.6 Sell
Chaikin Money Flow: 51250 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.09 - 14.07) Sell
Bollinger Bands (100): (12.94 - 13.86) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

DEA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.13 Sell
20-day SMA: 13.48 Sell
50-day SMA: 13.53 Sell
200-day SMA: 12.57 Sell
8-day EMA: 12.95 Sell
20-day EMA: 13.3 Sell
50-day EMA: 13.42 Sell
200-day EMA: 13.03 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Easterly Government Properties Earnings Growth & DEA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Easterly Government Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):